FAZ-053

CAT: 0804-HY-P991356Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991356Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
FAZ-053 is a human monoclonal antibody (mAb) targeting B7-H1/PD-L1/CD274. FAZ-053 inhibits the interaction of PD-L1 with PD-1 and B7-1 on monocytes, dendritic cells, and B cells. FAZ-053 enhances interleukin 2 production. FAZ-053 can be used in advanced alveolar soft tissue sarcoma (ASPS), chordoma, and triple-negative breast cancer research[1].
Product Name Alternative
LAE-005
UNSPSC
12352203
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[FAZ-053]
References & Citations
[1]Janku F, et al. First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies. ESMO Open. 2025 May 16;10 (6) :105051.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-162288-01FAZ-3532
HY-162289-01FAZ-3780
HY-135457-01JMS-053
HY-149359IHMT-IDH1-053
HY-101268CHMFL-ABL-053
HY-123426JY-XHe-053
HY-103078-01I-XW-053
HY-103078AI-XW-053 (sodium)
HY-115857SH-053-S-CH3-2'F
HY-12698-01NNC 63-0532

Alternative Products

CatalogName
MF-0100809-01FAZ-053
MF-0119522-01FAZ-3532
MF-0116637-01FAZ-3780
BA8108-10JMS-053
MBS5777407JY-XHe-053
MF-0156826-01IHMT-IDH1-053
MF-0051246-01CHMFL-ABL-053
MF-0018416-01I-XW-053
MBS5777351I-XW-053 sodium

Popular Products